Britain explores value of mixed jabs
2021-02-06 00:00
The United Kingdom has launched a clinical trial to determine whether alternating doses of the Oxford and Pfizer vaccines can provide effective protection against the coronavirus. If so, the mixed treatments could offer greater flexibility for vaccine rollouts. In the governmentfunded study, some volunteers will receive a first dose of the vaccine from the University of Oxford and AstraZeneca, followed by a second dose of the shot from Pfizer and BioNTech. Other participants will receive the jabs in reverse order. Researchers will then test antibody levels to ascertain whether the mixed treatments provoke an immune response that is weaker, stronger, or on par with conventional dosing.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html